A Phase 2a, Multicenter, Randomized, Double-blind, Placebo-controlled and Active-controlled, Parallel-group Study Evaluating the Analgesic Efficacy and Safety of V120083 in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee
Phase of Trial: Phase II
Latest Information Update: 13 Feb 2019
At a glance
- Drugs S 120083 (Primary) ; Naproxen
- Indications Inflammatory pain; Osteoarthritis
- Focus Therapeutic Use
- Sponsors Purdue Pharma L.P
- 13 Dec 2017 Status changed from active, no longer recruiting to completed.
- 11 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 02 Mar 2017 Status changed from not yet recruiting to recruiting.